{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T18:59:48Z","timestamp":1772477988286,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001823","name":"Ministerstvo \u0160kolstv\u00ed, Ml\u00e1de\u017ee a T\u011blov\u00fdchovy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002663","name":"Northwestern Polytechnical University","doi-asserted-by":"publisher","award":["LO 1304"],"award-info":[{"award-number":["LO 1304"]}],"id":[{"id":"10.13039\/501100002663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["IGA UP 2016-001"],"award-info":[{"award-number":["IGA UP 2016-001"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Genetics"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.cancergen.2016.06.004","type":"journal-article","created":{"date-parts":[[2016,6,14]],"date-time":"2016-06-14T07:27:31Z","timestamp":1465889251000},"page":"340-347","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Chromosomal aberrations in childhood acute lymphoblastic leukemia: 15-year single center experience"],"prefix":"10.1016","volume":"209","author":[{"given":"Marie","family":"Jarosova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jana","family":"Volejnikova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilona","family":"Porizkova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milena","family":"Holzerova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dagmar","family":"Pospisilova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zbynek","family":"Novak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jana","family":"Vrbkova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir","family":"Mihal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergen.2016.06.004_bib0010","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1182\/blood-2014-03-562918","article-title":"A novel integrated cytogenetic and genomic classification refines risk stratification in pediatric acute lymphoblastic leukemia","volume":"124","author":"Moorman","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2016.06.004_bib0015","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.blre.2012.01.001","article-title":"The clinical relevance of chromosomal and genomic abnormalities in B-cell precursor acute lymphoblastic leukemia","volume":"26","author":"Moorman","year":"2012","journal-title":"Blood Rev"},{"key":"10.1016\/j.cancergen.2016.06.004_bib0020","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1200\/JCO.2010.30.7405","article-title":"Biology, risk stratification, and therapy of pediatric acute leukemias: an update","volume":"29","author":"Pui","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cancergen.2016.06.004_bib0025","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1182\/blood-2012-10-462358","article-title":"Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL","volume":"122","author":"van der Veer","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2016.06.004_bib0030","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1182\/blood-2012-04-422691","article-title":"Tyrosine kinome sequencing of pediatric acute lymphoblastic leukemia: a report from the Children's Oncology Group TARGET Project","volume":"121","author":"Loh","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2016.06.004_bib0035","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/sj.leu.2404083","article-title":"Incidence of additional genetic changes in the TEL and AML1 genes in DCOG and COALL-treated t(12;21)-positive pediatric ALL, and their relation to drug sensitivity and clinical outcome","volume":"20","author":"Stams","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2016.06.004_bib0040","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1182\/blood-2009-03-208397","article-title":"Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia","volume":"114","author":"Russell","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2016.06.004_bib0045","doi-asserted-by":"crossref","first-page":"5393","DOI":"10.1182\/blood-2009-11-256131","article-title":"Presence of the P2RY8-CRLF2 rearrangement is associated with poor prognosis in non-high-risk precursor B-cell acute lymphoblastic leukemia in children treated according to the ALL-BFM 2000 protocol","volume":"115","author":"Cario","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2016.06.004_bib0050","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1056\/NEJMoa0808253","article-title":"Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia","volume":"360","author":"Mullighan","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cancergen.2016.06.004_bib0055","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/S0140-6736(08)61341-0","article-title":"Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome","volume":"372","author":"Bercovich","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.cancergen.2016.06.004_bib0060","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1056\/NEJMoa0808253","article-title":"Deletion of IKZF1 (Ikaros) and prognosis of acute lymphoblastic leukemia","volume":"360","author":"Mullighan","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cancergen.2016.06.004_bib0065","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/leu.2009.250","article-title":"Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Studies 82, 87, 88, 91 and 95 for childhood acute lymphoblastic leukemia","volume":"24","author":"Conter","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2016.06.004_bib0070","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1182\/blood-2009-10-248146","article-title":"Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study","volume":"115","author":"Conter","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2016.06.004_bib0075","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1200\/JCO.2011.37.8018","article-title":"Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group","volume":"30","author":"Hunger","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cancergen.2016.06.004_bib0080","doi-asserted-by":"crossref","DOI":"10.4149\/316_150910N482","article-title":"Treatment and prognosis of childhood acute lymphoblastic leukemia on protocols ALL-BFM 90, 95 and ALL IC-BFM 2002: a retrospective single-center study from Olomouc, Czech Republic","author":"Volejnikova","year":"2016","journal-title":"Neoplasma"},{"key":"10.1016\/j.cancergen.2016.06.004_bib0085","first-page":"3310","article-title":"Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group","volume":"95","author":"Schrappe","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2016.06.004_bib0090","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1182\/blood-2007-09-112920","article-title":"Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95","volume":"111","author":"Moricke","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2016.06.004_bib0095","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1200\/JCO.2013.48.6522","article-title":"Intensive chemotherapy for childhood acute lymphoblastic leukemia: results of the randomized intercontinental trial ALL IC-BFM 2002","volume":"32","author":"Stary","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cancergen.2016.06.004_bib0100","series-title":"ISCN (2009): An International System for Human Cytogenetic Nomenclature","author":"Shaffer","year":"2009"},{"key":"10.1016\/j.cancergen.2016.06.004_bib0105","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2016.06.004_bib0110","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0165-4608(03)00099-2","article-title":"Complex karyotypes in childhood acute lymphoblastic leukemia: cytogenetic and molecular cytogenetic study of 21 cases","volume":"145","author":"Jarosova","year":"2003","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergen.2016.06.004_bib0115","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1182\/asheducation-2013.1.118","article-title":"Targeting signaling pathways in acute lymphoblastic leukemia: new insights","volume":"2013","author":"Harrison","year":"2013","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.cancergen.2016.06.004_bib0120","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1600-0609.2009.01315.x","article-title":"Interphase FISH on TEL\/AML1 positive acute lymphoblastic leukemia relapses-analysis of clinical relevance of additional TEL and AML1 copy number changes","volume":"83","author":"Peter","year":"2009","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.cancergen.2016.06.004_bib0125","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1182\/blood-2010-03-275347","article-title":"ETV6\/RUNX1-positive relapses evolve from an ancestral clone and frequently acquire deletions of genes implicated in glucocorticoid signaling","volume":"117","author":"Kuster","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2016.06.004_bib0130","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3324\/haematol.2012.072470","article-title":"Copy number genome alterations are associated with treatment response and outcome in relapsed childhood ETV6\/RUNX1-positive acute lymphoblastic leukemia","volume":"99","author":"Bokemeyer","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.cancergen.2016.06.004_bib0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cancergen.2014.11.003","article-title":"Integration of cytogenomic data for furthering the characterization of pediatric B-cell acute lymphoblastic leukemia: a multi-institution, multi-platform microarray study","volume":"208","author":"Baughn","year":"2015","journal-title":"Cancer Genet"},{"key":"10.1016\/j.cancergen.2016.06.004_bib0135","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1349-7006.2007.00443.x","article-title":"Genetic abnormalities involved in t(12;21) TEL-AML1 acute lymphoblastic leukemia: analysis by means of array-based comparative genomic hybridization","volume":"98","author":"Tsuzuki","year":"2007","journal-title":"Cancer Sci"},{"key":"10.1016\/j.cancergen.2016.06.004_bib0140","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1182\/blood.V76.8.1626.1626","article-title":"Abnormalities of the long arm of chromosome 6 in childhood acute lymphoblastic leukemia","volume":"76","author":"Hayashi","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2016.06.004_bib0145","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1200\/JCO.1998.16.2.527","article-title":"Clinical significance of translocation t(1;19) in childhood acute lymphoblastic leukemia in the context of contemporary therapies: a report from the Children's Cancer Group","volume":"16","author":"Uckun","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cancergen.2016.06.004_bib0150","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0165-4608(99)00176-4","article-title":"Trisomy 5 as a sole cytogenetic abnormality in pediatric acute lymphoblastic leukemia","volume":"118","author":"Sandoval","year":"2000","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergen.2016.06.004_bib0155","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0165-4608(03)00272-3","article-title":"Is trisomy 5 a distinct cytogenetic subgroup in acute lymphoblastic leukemia?","volume":"148","author":"Harris","year":"2004","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergen.2016.06.004_bib0160","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/leu.2013.189","article-title":"Detecting dic(9;20)(p13.2;p11.2)-positive B-cell precursor acute lymphoblastic leukemia in clinical setting using fluorescence in situ hybridization","volume":"28","author":"Zachariadis","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2016.06.004_bib0165","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/leu.2010.318","article-title":"The frequency and prognostic impact of dic(9;20)(p13.2;q11.2) in childhood B-cell precursor acute lymphoblastic leukemia: results from the NOPHO ALL-2000 trial","volume":"25","author":"Zachariadis","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2016.06.004_bib0170","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00277-014-2204-z","article-title":"Detection of dicentric chromosome (9;20) in paediatric B-cell acute lymphoblastic leukaemia: prognostic significance","volume":"94","author":"Letouzey","year":"2015","journal-title":"Ann Hematol"},{"key":"10.1016\/j.cancergen.2016.06.004_bib0175","first-page":"1537","article-title":"Association of chromosome arm 9p abnormalities with adverse risk in childhood acute lymphoblastic leukemia: a report from the Children's Cancer Group","volume":"94","author":"Heerema","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2016.06.004_bib0180","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1182\/blood.V77.5.1050.1050","article-title":"Philadelphia chromosome and monosomy 7 in childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study","volume":"77","author":"Russo","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2016.06.004_bib0185","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cancergencyto.2006.03.016","article-title":"Dicentric (7;9)(p11;p11) is a rare but recurrent abnormality in acute lymphoblastic leukemia: a study of 7 cases","volume":"169","author":"Pan","year":"2006","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergen.2016.06.004_bib0190","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1365-2141.2012.09083.x","article-title":"Genome-wide analysis of cytogenetic aberrations in ETV6\/RUNX1-positive childhood acute lymphoblastic leukaemia","volume":"157","author":"Borst","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergen.2016.06.004_bib0195","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/leu.2013.317","article-title":"An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcome","volume":"28","author":"Harrison","year":"2014","journal-title":"Leukemia"}],"container-title":["Cancer Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776216302046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776216302046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:41:33Z","timestamp":1761896493000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210776216302046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":39,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S2210776216302046"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergen.2016.06.004","relation":{},"ISSN":["2210-7762"],"issn-type":[{"value":"2210-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chromosomal aberrations in childhood acute lymphoblastic leukemia: 15-year single center experience","name":"articletitle","label":"Article Title"},{"value":"Cancer Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cancergen.2016.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}